1. Home
  2. MTEX vs RLMD Comparison

MTEX vs RLMD Comparison

Compare MTEX & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEX
  • RLMD
  • Stock Information
  • Founded
  • MTEX 1993
  • RLMD 2004
  • Country
  • MTEX United States
  • RLMD United States
  • Employees
  • MTEX N/A
  • RLMD N/A
  • Industry
  • MTEX Medicinal Chemicals and Botanical Products
  • RLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTEX Health Care
  • RLMD Health Care
  • Exchange
  • MTEX Nasdaq
  • RLMD Nasdaq
  • Market Cap
  • MTEX 20.0M
  • RLMD 22.0M
  • IPO Year
  • MTEX 1999
  • RLMD N/A
  • Fundamental
  • Price
  • MTEX $8.98
  • RLMD $0.61
  • Analyst Decision
  • MTEX
  • RLMD Buy
  • Analyst Count
  • MTEX 0
  • RLMD 3
  • Target Price
  • MTEX N/A
  • RLMD $5.00
  • AVG Volume (30 Days)
  • MTEX 11.0K
  • RLMD 439.6K
  • Earning Date
  • MTEX 08-12-2025
  • RLMD 08-06-2025
  • Dividend Yield
  • MTEX N/A
  • RLMD N/A
  • EPS Growth
  • MTEX N/A
  • RLMD N/A
  • EPS
  • MTEX N/A
  • RLMD N/A
  • Revenue
  • MTEX $115,036,000.00
  • RLMD N/A
  • Revenue This Year
  • MTEX N/A
  • RLMD N/A
  • Revenue Next Year
  • MTEX N/A
  • RLMD N/A
  • P/E Ratio
  • MTEX N/A
  • RLMD N/A
  • Revenue Growth
  • MTEX N/A
  • RLMD N/A
  • 52 Week Low
  • MTEX $6.75
  • RLMD $0.24
  • 52 Week High
  • MTEX $16.49
  • RLMD $4.47
  • Technical
  • Relative Strength Index (RSI)
  • MTEX 46.49
  • RLMD 47.24
  • Support Level
  • MTEX $8.69
  • RLMD $0.67
  • Resistance Level
  • MTEX $11.36
  • RLMD $0.74
  • Average True Range (ATR)
  • MTEX 0.67
  • RLMD 0.07
  • MACD
  • MTEX -0.04
  • RLMD -0.03
  • Stochastic Oscillator
  • MTEX 28.46
  • RLMD 25.79

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: